Skip to main content
Fig. 5 | Biomarker Research

Fig. 5

From: MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures

Fig. 5

Comparison of the prognostic performance of the radiomic model with the clinical tumor-node-metastasis (cTNM) stage and pathological tumor-node-metastasis (pTNM) stage on the prospective subset 1 (n = 75 prospective patients). (A/B) Kaplan-Meier curves for the cTNM/pTNM, with low-risk corresponding to cTNM/pTNM stage = III and high-risk corresponding to cTNM/pTNM stage = IV. Shadows represent 95% confidence interval. (C) Kaplan-Meier curves for the radiomic signature. Shadows represent 95% confidence interval. (D) Concordance indexes (C-index) for the cTNM, pTNM and radiomic signatures. *p < 0.05 (Kruskal-Wallis with Tukey-Kramer correction)

Back to article page